Core Insights - Baird Medical showcased its minimally invasive microwave ablation (MWA) technology at NASIT 2025, generating significant interest and discussions among clinicians regarding future thyroid therapies [1][3] - Dr. Emad Kandil presented compelling case studies highlighting MWA as a safe and effective alternative to traditional thyroid surgery, emphasizing benefits such as reduced procedure times and improved patient outcomes [2] - The company aims to enhance treatment options through further research and strategic partnerships, reinforcing its commitment to innovation in patient care [3][4] Company Overview - Baird Medical is a leading provider of minimally invasive MWA technology, focusing on advanced treatment solutions for conditions like thyroid nodules, breast disease, uterine fibroids, and liver cancer [4] - The company is publicly traded on NASDAQ and is dedicated to improving patient care through precision, efficiency, and safety in its medical devices [4]
Baird Medical Showcases Groundbreaking MWA Innovations at NASIT 2025